Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 108 in Subjects With Osteoarthritis
NCT00110942Phase 2Completed
- Sponsor
- Amgen
- Start
- Feb 2005
- Primary completion
- Jun 2005
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of AMG 108 in osteoarthritis (OA), sponsored by Amgen. Started Feb 2005; status: completed.
02
Drugs
AMG 108
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00110942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110942.